Breast cancer treatment
51 – 60 of 256
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Hormone receptor mRNA and protein levels as predictors of premenopausal tamoxifen benefit
- Contribution to journal › Article
- 2023
-
Mark
Breast Cancer Diagnosis Using Extended-Wavelength–Diffuse Reflectance Spectroscopy (EW-DRS) : Proof of Concept in Ex Vivo Breast Specimens Using Machine Learning
- Contribution to journal › Article
-
Mark
Longitudinal Assessment of Circulating Tumor Cells and Outcome in Small Cell Lung Cancer : A Sub-Study of RASTEN—A Randomized Trial with Low Molecular Weight Heparin
- Contribution to journal › Article
-
Mark
Breast cancer survival and incidence of second primary cancers after 30 years in a randomized study of two versus five years of adjuvant tamoxifen therapy
- Contribution to journal › Article
-
Mark
Mammographic density in relation to breast cancer recurrence and survival in women receiving neoadjuvant chemotherapy
- Contribution to journal › Article
-
Mark
Matched analysis of circulating selenium with the breast cancer selenotranscriptome: a multicentre prospective study
(2023) In Journal of Translational Medicine
- Contribution to journal › Article
-
Mark
A prospective cohort study identifying radiologic and tumor related factors of importance for breast conserving surgery after neoadjuvant chemotherapy
- Contribution to journal › Article
-
Mark
Risk factors for seroma formation after axillary lymph node dissection with special focus on the impact of early shoulder exercise
- Contribution to journal › Article
-
Mark
Combining histological grade, TILs, and the PD-1/PD-L1 pathway to identify immunogenic tumors and de-escalate radiotherapy in early breast cancer : A secondary analysis of a randomized clinical trial
- Contribution to journal › Article
-
Mark
Artificial intelligence-supported screen reading versus standard double reading in the Mammography Screening with Artificial Intelligence trial (MASAI) : a clinical safety analysis of a randomised, controlled, non-inferiority, single-blinded, screening accuracy study
- Contribution to journal › Article
